Effects of Darbepoetin Alfa with exercise in cancer patients undergoing chemotherapy: An explorative study

Scandinavian Journal of Medicine and Science in Sports

Volumn 21, Issue 3, 2011, Pages 369-377

  Rorth M ^a   Madsen, K R ^a   Burmolle S H ^a   Midtgaard, J ^a   Andersen, C ^a   Nielsen, B ^a   Stage, M ^a   Adamsen, L ^a  

^a Mental Health Center Glostrup   (Denmark)

Author keywords

Cancer patients; Chemotherapy; EPO; Exercise intervention; Fatigue

Indexed keywords

ANTIANEMIC AGENT; DRUG DERIVATIVE; ERYTHROPOIETIN; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; DRUG THERAPY; FATIGUE; FEMALE; HUMAN; KINESIOTHERAPY; MALE; MIDDLE AGED; NEOPLASM; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; DRUG THERAPY; ERYTHROPOIETIN; EXERCISE THERAPY; FATIGUE; FEMALE; HEMATINICS; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79955953387     PISSN: 09057188     EISSN: 16000838     Source Type: Journal    
DOI: 10.1111/j.1600-0838.2009.01066.x     Document Type: Article

References (35)

1. Adamsen L, Andersen C, Midtgaard J, Møller T, Quist M, Rørth M. Struggling with cancer and treatment: young athletes recapture body control and identity through exercise: qualitative findings from a supervised group exercise program in cancer patients of mixed gender undergoing chemotherapy. Scand J Med Sci Sports 2009a: 19: 55-66.
2. Adamsen L, Midtgaard J, Roerth M, Andersen C, Quist M, Moeller T. Transforming the nature of fatigue through exercise: qualitative findings from a multidimensional exercise programme in cancer patients undergoing chemotherapy. Eur J Cancer Care 2004: 13: 362-370.
3. Adamsen L, Midtgaard J, Rorth M, Borregaard N, Andersen C, Quist M, Møller T, Zacho M, Madsen JK, Knutsen L. Feasibility, physical capacity, and health benefits of a multidimensional exercise program for cancer patients undergoing chemotherapy. Support Care Cancer 2003: 11: 707-716.
4. Adamsen L, Quist M, Andersen C, Møller T, Herrstedt J, Kronborg D, Baadsgaard MT, Vistisen K, Midtgaard J, Christiansen B, Stage M, Kronborg M, Rørth M. Effect of a multimodal high intensity exercise intervention in cancer patients undergoing chemotherapy: randomised controlled trial. BMJ 2009b: 339: b3410.
5. Adamsen L, Quist M, Midtgaard J, Andersen C, Møller T, Knutsen L, Tveterås A, Rorth M. The effect of a multidimensional exercise intervention on physical capacity, well-being and quality of life in cancer patients undergoing chemotherapy. Support Care Cancer 2006: 14: 116-127.
6. Andersen C, Adamsen L, Moeller T, Midtgaard J, Quist M, Tveteraas A, Rorth M. The effect of a multidimensional exercise programme on symptoms and side-effects in cancer patients undergoing chemotherapy: the use of semi-structured diaries. Eur J Oncol Nurs 2006: 10: 247-262.
7. Cassileth BR, Vickers AJ. Massage therapy for symptom control: outcome study at a major cancer center. J Pain Symptom Manage 2004: 28: 244-249.
8. Coleman EA, Coon SK, Kennedy RL, Lockhart KD, Stewart CB, Anaissie EJ, Barlogie B. Effects of exercise in combination with epoetin alfa during high-dose chemotherapy and autologous peripheral blood stem cell transplantation for multiple myeloma. Oncol Nurs Forum 2008: 35: E53-E61.
9. Courneya KS, Jones LW, Peddle CJ, Sellar CM, Reiman T, Joy AA, Chua N, Tkachuk L, Mackey JR. Effects of aerobic exercise training in anemic cancer patients receiving Darbepoetin Alfa: a randomized controlled trial. Oncologist 2008: 13: 1012-1020.
10. Crabtree BF, Miller WL, eds. Doing qualitative research, 2nd edn. Thousand Oaks, CA: Sage Publications, 1999.
11. Dimeo FC, Stieglitz RD, Novelli-Fischer U, Fetscher S, Keul J. Effects of physical activity on the fatigue and psychologic status of cancer patients during chemotherapy. Cancer 1999: 85: 2273-2277.
12. Fallowfield L, Gagnon D, Zagari M. Treating anaemia with epoetin alfa is associated with improvements in quality of life in cancer patients receiving chemotherapy. Curr Med Res Opin 2005: 21 (Suppl. 2): S9-S11.
13. Galvão DA, Newton RU. Review of exercise intervention studies in cancer patients. J Clin Oncol 2005: 23: 899-909.
14. Giorgi A. Sketch of a psychological phenomenological method. In: Giorgi A, ed. Phenomenology and psychological research. Pittsburgh, PA: Duquesne University Press, 1985: 8-22.
15. Henke M, Laszig R, Rübe C, Schäfer U, Haase KD, Schilcher B, Mose S, Beer KT, Burger U, Dougherty C, Frommhold H. Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial. Lancet 2003: 362: 1255-1260.
16. Henry DH, Viswanathan HN, Elkin EP, Traina S, Wade S, Cella D. Symptoms and treatment burden associated with cancer treatment: results from a cross-sectional national survey in the US. Support Care Cancer 2008: 16: 791-801.
17. Iconomou G, Koutras A, Rigopoulos A, Vagenakis AG, Kalofonos HP. Effect of recombinant human erythropoietin on quality of life in cancer patients receiving chemotherapy: results of a randomized, controlled trial. J Pain Symptom Manage 2003: 25: 512-518.
18. Kallich J, McDermott A, Xu X, Fayers P, Cella D. The relationship between patient knowledge of hemoglobin levels and health-related quality of life. Qual Life Res 2006: 15: 57-68.
19. Layder D. Sociological practice: linking theory and social research. London: Sage Publications, 1998.
20. Littlewood TJ, Bajetta E, Nortier JW, Vercammen E, Rapoport B. Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: results of a randomized, double-blind, placebo-controlled trial. J Clin Oncol 2001: 19: 2865-2874.
21. Luebbert K, Dahme B, Hasenbring M. The effectiveness of relaxation training in reducing treatment-related symptoms and improving emotional adjustment in acute non-surgical cancer treatment: a meta-analytical review. Psychooncology 2001: 10: 490-502.
22. Lundby C, Robach P, Boushel R, Thomsen JJ, Rasmussen P, Koskolou M, Calbet JA. Does recombinant human Epo increase exercise capacity by means other than augmenting oxygen transport? J Appl Physiol 2008: 105: 581-587.
23. Maiese K, Li F, Chong ZZ. New avenues of exploration for erythropoietin. JAMA 2005: 293: 90-95.
24. Malterud K. Qualitative research: standards, challenges, and guidelines. Lancet 2001: 358: 483-488.
25. Midtgaard J, Rorth M, Stelter R, Adamsen L. The Group Matters: an explorative study of group cohesion and quality of life in cancer patients participating in physical exercise intervention during treatment. Eur J Cancer Care 2006a: 15: 25-33.
26. Midtgaard J, Rørth M, Stelter R, Tveterås A, Andersen C, Quist M, Møller T, Adamsen L. The impact of a multidimensional exercise program on self-reported anxiety and depression in cancer patients undergoing chemotherapy: a phase II study. Palliat Support Care 2005: 3: 197-208.
27. Miskowiak K, Inkster B, O'Sullivan U, Selvaraj S, Goodwin GM, Harmer CJ. Differential effects of erythropoietin on neural and cognitive measures of executive function 3 and 7 days post-administration. Exp Brain Res 2008a: 184: 313-321.
28. Miskowiak K, Inkster B, Selvaraj S, Wise R, Goodwin GM, Harmer CJ. Erythropoietin improves mood and modulates the cognitive and neural processing of emotion 3 days post administration. Neuropsychopharmacology 2008b: 33: 611-618.
29. Mock V. Evidence-based treatment for cancer-related fatigue. J Natl Cancer Inst Monogr 2004: 2004 (32): 112-118.
30. Mock V, Pickett M, Ropka ME, Muscari Lin E, Stewart KJ, Rhodes VA, McDaniel E, Grimm PM, Krumm S, McCorkle R. Fatigue and quality of life outcomes of exercise during cancer treatment. Cancer Practice 2001: 9: 119-127.
31. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: cancer-related fatigue: version 1.2008. Rockledge, PA: National Comprehensive Cancer Network, 2008.
32. Patton MQ. Qualitative evaluation and research methods, 2nd edn. Beverly Hills, CA: Sage, 1990.
33. Quist M, Rorth M, Zacho M, Andersen C, Moeller T, Midtgaard J, Adamsen L. High-intensity resistance and cardiovascular training improve physical capacity in cancer patients undergoing chemotherapy. Scand J Med Sci Sports 2006: 16: 349-357.
34. Schwartz AL. Fatigue mediates the effects of exercise on quality of life. Qual Life Res 1999: 8: 529-538.
35. Suzuki Y, Tokuda Y, Fujiwara Y, Minami H, Ohashi Y, Saijo N. Weekly epoetin beta maintains haemoglobin levels and improves quality of life in patients with non-myeloid malignancies receiving chemotherapy. Jpn J Clin Oncol 2008: 38: 214-221.